Checkpoint Therapeutics logo
Checkpoint Therapeutics CKPT

Quarterly report 2025-Q1
added 05-13-2025

report update icon

Checkpoint Therapeutics Gross Profit 2011-2025 | CKPT

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Checkpoint Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 1.07 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.07 1.07 1.07

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
AbbVie AbbVie
ABBV
10.7 B $ 223.01 -0.99 % $ 395 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-40.6 M $ 4.68 1.85 % $ 777 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
172 K $ 3.38 3.21 % $ 261 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-32.3 K - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
1.12 M - -15.15 % $ 60.3 M britainBritain
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
319 M $ 212.3 5.5 % $ 5 B danmarkDanmark
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
90 K - - $ 7.46 M israelIsrael
Aptorum Group Limited Aptorum Group Limited
APM
-104 K $ 1.33 -1.48 % $ 7.25 M chinaChina
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
177 K $ 3.4 1.49 % $ 8.18 B australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
43.9 B $ 90.34 -1.28 % $ 96.9 B britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
374 M $ 25.76 0.19 % $ 1.25 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
103 M $ 9.53 -1.19 % $ 140 M usaUSA
Brickell Biotech Brickell Biotech
BBI
1.82 K - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
3.22 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Biogen Biogen
BIIB
12.4 B $ 173.03 -2.55 % $ 25.2 B usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
500 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
53.8 M - -7.31 % $ 87 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
45.8 M $ 2.33 2.3 % $ 14.6 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
319 K - -6.81 % $ 3.04 B usaUSA
Baudax Bio Baudax Bio
BXRX
-1.24 M - 0.59 % $ 63 K usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
109 M $ 15.32 5.73 % $ 1.01 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
ChromaDex Corporation ChromaDex Corporation
CDXC
61.6 M - -0.88 % $ 598 M usaUSA
Axon Enterprise Axon Enterprise
AXON
1.24 B $ 586.28 3.15 % $ 44.4 B usaUSA
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.14 13.23 % $ 395 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
4.15 M - -16.75 % $ 25.8 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
5.48 M $ 28.33 0.5 % $ 1.82 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
123 M - -7.23 % $ 13 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.03 M $ 0.29 -5.01 % $ 631 M israelIsrael
Benitec Biopharma Benitec Biopharma
BNTC
282 K $ 12.91 0.78 % $ 531 M usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
-57.6 M $ 60.38 0.11 % $ 6.76 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
371 M $ 11.55 8.86 % $ 747 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
15.8 M $ 10.89 -0.09 % $ 1.42 B usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
200 K - -5.68 % $ 8.28 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
1.27 M - 2.71 % $ 14 M usaUSA